These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21969039)

  • 1. Synthesis and oxidation of 2-hydroxynevirapine, a metabolite of the HIV reverse transcriptase inhibitor nevirapine.
    Antunes AM; Novais DA; da Silva JL; Santos PP; Oliveira MC; Beland FA; Marques MM
    Org Biomol Chem; 2011 Oct; 9(22):7822-35. PubMed ID: 21969039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid adduct formation by the nevirapine metabolite, 12-hydroxynevirapine--a possible factor in nevirapine toxicity.
    Antunes AM; Godinho AL; Martins IL; Justino GC; Beland FA; Marques MM
    Chem Res Toxicol; 2010 May; 23(5):888-99. PubMed ID: 20392079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of 2-hydroxynevirapine, a phenolic metabolite of the anti-HIV drug nevirapine: evidence for an unusual pyridine ring contraction.
    Antunes AM; Sidarus M; Novais DA; Harjivan SG; Santos PP; Ferreira da Silva JL; Beland FA; Marques MM
    Molecules; 2012 Mar; 17(3):2616-27. PubMed ID: 22391597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
    van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
    J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of DNA adducts from the HIV reverse transcriptase inhibitor nevirapine.
    Antunes AM; Duarte MP; Santos PP; Gamboa da Costa G; Heinze TM; Beland FA; Marques MM
    Chem Res Toxicol; 2008 Jul; 21(7):1443-56. PubMed ID: 18597499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.
    Krogstad P; Lee S; Johnson G; Stanley K; McNamara J; Moye J; Jackson JB; Aguayo R; Dieudonne A; Khoury M; Mendez H; Nachman S; Wiznia A;
    Clin Infect Dis; 2002 Apr; 34(7):991-1001. PubMed ID: 11880966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.
    Soriano V; Arastéh K; Migrone H; Lutz T; Opravil M; Andrade-Villanueva J; Antunes F; Di Perri G; Podzamczer D; Taylor S; Domingo P; Gellermann H; de Rossi L;
    Antivir Ther; 2011; 16(3):339-48. PubMed ID: 21555816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine resistance after single dose prophylaxis.
    Eshleman SH; Jackson JB
    AIDS Rev; 2002; 4(2):59-63. PubMed ID: 12152519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein adducts as prospective biomarkers of nevirapine toxicity.
    Antunes AM; Godinho AL; Martins IL; Oliveira MC; Gomes RA; Coelho AV; Beland FA; Marques MM
    Chem Res Toxicol; 2010 Nov; 23(11):1714-25. PubMed ID: 20809596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.
    Cywin CL; Klunder JM; Hoermann M; Brickwood JR; David E; Grob PM; Schwartz R; Pauletti D; Barringer KJ; Shih CK; Sorge CL; Erickson DA; Joseph DP; Hattox SE
    J Med Chem; 1998 Jul; 41(16):2972-84. PubMed ID: 9685236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
    Eshleman SH; Becker-Pergola G; Deseyve M; Guay LA; Mracna M; Fleming T; Cunningham S; Musoke P; Mmiro F; Jackson JB
    J Infect Dis; 2001 Oct; 184(7):914-7. PubMed ID: 11509999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy.
    Sankatsing RR; Wit FW; Pakker N; Vyankandondera J; Mmiro F; Okong P; Kastelein JJ; Lange JM; Stroes ES; Reiss P
    J Infect Dis; 2007 Jul; 196(1):15-22. PubMed ID: 17538878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-Deoxythymidine adducts from the anti-HIV drug nevirapine.
    Antunes AM; Wolf B; Oliveira MC; Beland FA; Marques MM
    Molecules; 2013 Apr; 18(5):4955-71. PubMed ID: 23624649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE
    J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hepatic failure related to nevirapine treatment.
    Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.